Cargando…
DOT1L inhibition blocks multiple myeloma cell proliferation by suppressing IRF4-MYC signaling
Epigenetic alterations play an important role in the pathogenesis in multiple myeloma, but their biological and clinical relevance is not fully understood. Here, we show that DOT1L, which catalyzes methylation of histone H3 lysine 79, is required for myeloma cell survival. DOT1L expression levels we...
Autores principales: | Ishiguro, Kazuya, Kitajima, Hiroshi, Niinuma, Takeshi, Ishida, Tadao, Maruyama, Reo, Ikeda, Hiroshi, Hayashi, Toshiaki, Sasaki, Hajime, Wakasugi, Hideki, Nishiyama, Koyo, Shindo, Tetsuya, Yamamoto, Eiichiro, Kai, Masahiro, Sasaki, Yasushi, Tokino, Takashi, Nakase, Hiroshi, Suzuki, Hiromu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6312027/ https://www.ncbi.nlm.nih.gov/pubmed/30171029 http://dx.doi.org/10.3324/haematol.2018.191262 |
Ejemplares similares
-
Dual EZH2 and G9a inhibition suppresses multiple myeloma cell proliferation by regulating the interferon signal and IRF4-MYC axis
por: Ishiguro, Kazuya, et al.
Publicado: (2021) -
UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells
por: Niinuma, Takeshi, et al.
Publicado: (2019) -
TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells
por: Kai, Masahiro, et al.
Publicado: (2016) -
DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes
por: Hatanaka, Yui, et al.
Publicado: (2021) -
Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancer
por: Shindo, Tetsuya, et al.
Publicado: (2018)